lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Global Incidence Trends in Very-Early-, Early-, and Late-Onset Primary Liver Cancer by Sex, Region, and Aetiology: A Study Based on Global Burden of Disease Study 2017

32 Pages Posted: 30 Apr 2019

See all articles by Zhenqiu Liu

Zhenqiu Liu

Fudan University - State Key Laboratory of Genetic Engineering

Chen Suo

Fudan University - Department of Epidemiology and Health Statistics; Fudan University - Key Laboratory of Public Health Safety; Fudan University - Department of Epidemiology

Xianhua Mao

Fudan University - State Key Laboratory of Genetic Engineering; Fudan University - Collaborative Innovation Center for Genetics and Development; Fudan University - Taizhou Institute of Health Sciences

Yanfeng Jiang

Fudan University - Collaborative Innovation Center for Genetics and Development; Fudan University - State Key Laboratory of Genetic Engineering; Fudan University - Taizhou Institute of Health Sciences

Li Jin

Fudan University - Collaborative Innovation Center for Genetics and Development; Fudan University - State Key Laboratory of Genetic Engineering; Fudan University - Taizhou Institute of Health Sciences; Fudan University - Human Phenome Institute

Tiejun Zhang

Fudan University - Department of Epidemiology

Xingdong Chen

Fudan University - State Key Laboratory of Genetic Engineering; Fudan University - Collaborative Innovation Center for Genetics and Development; Fudan University - Human Phenome Institute; Fudan University - Taizhou Institute of Health Sciences

More...

Abstract

Background: The incidence of liver cancer continues to increase worldwide. The incidence trends and onset patterns of liver cancer associated with different onset ages remain unknown.  

Methods: We collected detailed information on liver cancer between 1990 and 2017 from the Global Burden of Disease Study (GBD) study 2017. Estimated annual percentage changes (EAPCs) in the liver cancer age-standardized incidence rate (ASR) by onset age, sex, region, and aetiology were calculated to quantify the temporal trends in liver cancer ASR.  

Findings: The ASR of very-early-onset (onset at < 30 years) and earlyonset (onset from 30-59 years) liver cancer decreased in both sexes, whereas the ASR of late-onset (onset at ≥ 60 years) liver cancer increased in males (EAPC = 0.64, 95% confidence interval [CI] 0.52, 0.75) and remained stable in females at the global level. Males had a more dramatic increase in late-onset liver cancer but a milder decrease in early-onset liver cancer than females. The decrease was largely ascribed to the reduction in liver cancer caused by hepatitis B and hepatitis C and was consistent in most regions except in developed countries, in which the ASR of liver cancer increased irrespective of sex and onset age. The ASR of liver cancer due to non-alcoholic steatohepatitis (NASH) increased by the greatest magnitude in most regions.

Interpretation: Liver cancer in highly endemic regions has been partly alleviated due to the potent control of hepatitis, especially among young and middle-aged people. However, an unfavourable trend was observed in most developed countries and in elderly populations. NASH and older people deserve more attention in liver cancer primary prevention schedules.  

Funding Statement: This work was supported by the National Key Research and Development Program of China (grant number: 2017YFC0907002, 2017YFC0907501, 2017YFC211700); the National Natural Science Foundation of China (grant numbers: 81772170, 81502870); the key basic research grants from the Science and Technology Commission of Shanghai Municipality (grant number: 16JC1400500); the International S&T Cooperation Program of China (grant number: 2015DFE32790); and Shanghai Municipal Science and Technology Major Project (2017SHZDZX01)

Declaration of Interests: The authors declare no conflicts of interest.

Keywords: liver cancer; incidence; onset age; HBV; HCV; NASH

Suggested Citation

Liu, Zhenqiu and Suo, Chen and Mao, Xianhua and Jiang, Yanfeng and Jin, Li and Zhang, Tiejun and Chen, Xingdong, Global Incidence Trends in Very-Early-, Early-, and Late-Onset Primary Liver Cancer by Sex, Region, and Aetiology: A Study Based on Global Burden of Disease Study 2017 (04/26/2019 02:50:25). Available at SSRN: https://ssrn.com/abstract=3378703 or http://dx.doi.org/10.2139/ssrn.3378703

Zhenqiu Liu

Fudan University - State Key Laboratory of Genetic Engineering

Shanghai
China

Chen Suo

Fudan University - Department of Epidemiology and Health Statistics

Shanghai
China

Fudan University - Key Laboratory of Public Health Safety

Shanghai
China

Fudan University - Department of Epidemiology

Shanghai
China

Xianhua Mao

Fudan University - State Key Laboratory of Genetic Engineering

Shanghai
China

Fudan University - Collaborative Innovation Center for Genetics and Development

China

Fudan University - Taizhou Institute of Health Sciences

Taizhou
China

Yanfeng Jiang

Fudan University - Collaborative Innovation Center for Genetics and Development

China

Fudan University - State Key Laboratory of Genetic Engineering

Shanghai
China

Fudan University - Taizhou Institute of Health Sciences

Taizhou
China

Li Jin

Fudan University - Collaborative Innovation Center for Genetics and Development

China

Fudan University - State Key Laboratory of Genetic Engineering

Shanghai
China

Fudan University - Taizhou Institute of Health Sciences

Taizhou
China

Fudan University - Human Phenome Institute

Shanghai
China

Tiejun Zhang

Fudan University - Department of Epidemiology

Shanghai
China

Xingdong Chen (Contact Author)

Fudan University - State Key Laboratory of Genetic Engineering ( email )

Shanghai
China

Fudan University - Collaborative Innovation Center for Genetics and Development

China

Fudan University - Human Phenome Institute ( email )

Shanghai
China

Fudan University - Taizhou Institute of Health Sciences ( email )

Taizhou
China

Click here to go to TheLancet.com

Paper statistics

Abstract Views
108
Downloads
4